GB:0RK9 Stock Latest News
PremiumCompany AnnouncementsAlligator Bioscience Secures Capital Through Directed Share Issue Alligator Bioscience’s HLX22 Receives European Orphan Drug Designation Alligator Bioscience Showcases Promising OPTIMIZE-1 Trial Results at ASCO 2025 PremiumCompany AnnouncementsAlligator Bioscience to Present at ASCO 2025 Annual Meeting Alligator Bioscience Secures 85% of Warrant Programme and Renegotiates Loan to Advance Mitazalimab Alligator Bioscience Advances Mitazalimab with Successful Phase 3 Manufacturing